Hormonal contraception, as a class, can be used to correct menstrual abnormalities, increase predictability and reduce blood loss, among other benefits.
Consider hormonal contraception to address the following:
Control of menstrual bleeding is a significant benefit of hormonal contraception methods. In addition, OC users have a 50% reduction in risk of endometrial cancer, a benefit that persists for up to 20 years after use. The levonorgestrel intrauterine system effectively treats endometrial hyperplasia without atypia; however, data are limited in its role in hyperplasia with atypia. Reduction in risk of ovarian cancer parallels the duration of combined OC use, with a decrease of about 20% for every 5 years of use. Recent, but not past, use of OCs appears to lower risk of colorectal cancer.
ACOG Practice Bulletin No. 110 : Noncontraceptive Uses of Hormonal Contraceptives
Please log in to ObGFirst to access the 2T US Atlas
OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Jointly provided by
